HealthPartners issued a positive coverage decision for minimally invasive sacroiliac (SI) joint fusion surgery, expanding patient access to RTI Surgical’s (RTIX) SImmetry System. The coverage is dated November 1, 2018.
As the reported largest consumer-governed nonprofit healthcare organization in the U.S., HealthPartners covers more than 1 million lives in Iowa, Minnesota and Wisconsin.
SImmetry is a minimally-invasive procedure that uses proprietary decortication technology, bone graft and threaded fixation to facilitate bone fusion. SI joint fusion using the SImmetry System is designed to stabilize the dysfunctional SI joint by fusing the sacrum and pelvic bone together. As previously reported, with use of SImmetry, mean low back pain measures demonstrated a significant 54% reduction, with 72% of patients reaching the minimal clinically important difference. A 55% reduction in opioid use was reported to be much greater than previously cited in other studies. One- and two-year follow-up will assess the presence of bony fusion across the joint, as well as ongoing pain reduction.
RTIX acquired the system with its purchase of Zyga in early 2018.
In 2015, analysts estimated the SI joint treatment market at under $70MM. Earlier this year, RTIX leadership cited an estimated $100MM market in the U.S., slated to exceed $200MM by 2024, with SI joint fusion procedures growing 20%.
HealthPartners issued a positive coverage decision for minimally invasive sacroiliac (SI) joint fusion surgery, expanding patient access to RTI Surgical’s (RTIX) SImmetry System. The coverage is dated November 1, 2018.
As the reported largest consumer-governed nonprofit healthcare organization in the U.S., HealthPartners covers more than 1...
HealthPartners issued a positive coverage decision for minimally invasive sacroiliac (SI) joint fusion surgery, expanding patient access to RTI Surgical’s (RTIX) SImmetry System. The coverage is dated November 1, 2018.
As the reported largest consumer-governed nonprofit healthcare organization in the U.S., HealthPartners covers more than 1 million lives in Iowa, Minnesota and Wisconsin.
SImmetry is a minimally-invasive procedure that uses proprietary decortication technology, bone graft and threaded fixation to facilitate bone fusion. SI joint fusion using the SImmetry System is designed to stabilize the dysfunctional SI joint by fusing the sacrum and pelvic bone together. As previously reported, with use of SImmetry, mean low back pain measures demonstrated a significant 54% reduction, with 72% of patients reaching the minimal clinically important difference. A 55% reduction in opioid use was reported to be much greater than previously cited in other studies. One- and two-year follow-up will assess the presence of bony fusion across the joint, as well as ongoing pain reduction.
RTIX acquired the system with its purchase of Zyga in early 2018.
In 2015, analysts estimated the SI joint treatment market at under $70MM. Earlier this year, RTIX leadership cited an estimated $100MM market in the U.S., slated to exceed $200MM by 2024, with SI joint fusion procedures growing 20%.
Copy to clipboard 
